| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.034 | 0.7 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.7 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |